How does the octreotide (Sandostatin) work to control VIPoma-related diarrhea? Case summary: J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness.

Question

Want to see the full answer?

Answer 1

Question

Chapter 30, Problem 1CS

(1)

Summary Introduction

To determine:

How does the octreotide (Sandostatin) work to control VIPoma-related diarrhea?

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness.

(2)

Summary Introduction

To predict:

J.R. begins the octreotide (Sandostatin) therapy, what parameters the nurse should assess.

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness.

(3)

Summary Introduction

To determine:

What is an explanation for this elevation?

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness. After two days of octreotide (Sandostatin) therapy, the episodes of diarrhea have been reduced. The nurse records that her blood glucose levels are elevated.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

how can we fix abnormal vital signs?

Data were measured in 15 college seniors (n = 15) in a cross-sectional study of alcohol consumption. Each participant was asked their sex, year in school, the age at which they first consumed alcohol, and the number of alcoholic drinks they consume on a typical drinking night. The data are shown in Table 3.4. Generate frequency distribution tables for sex and year in school using the Data/Pivot Table and Pivot Chart Report option on the menu bar.

Generate a frequency bar chart for sex using the frequency distribution table from Problem 1.

Answer 2

Question

Chapter 30, Problem 1CS

(1)

Summary Introduction

To determine:

How does the octreotide (Sandostatin) work to control VIPoma-related diarrhea?

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness.

(2)

Summary Introduction

To predict:

J.R. begins the octreotide (Sandostatin) therapy, what parameters the nurse should assess.

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness.

(3)

Summary Introduction

To determine:

What is an explanation for this elevation?

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness. After two days of octreotide (Sandostatin) therapy, the episodes of diarrhea have been reduced. The nurse records that her blood glucose levels are elevated.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Answer 3

Question

Chapter 30, Problem 1CS

(1)

Summary Introduction

To determine:

How does the octreotide (Sandostatin) work to control VIPoma-related diarrhea?

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness.

(2)

Summary Introduction

To predict:

J.R. begins the octreotide (Sandostatin) therapy, what parameters the nurse should assess.

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness.

(3)

Summary Introduction

To determine:

What is an explanation for this elevation?

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness. After two days of octreotide (Sandostatin) therapy, the episodes of diarrhea have been reduced. The nurse records that her blood glucose levels are elevated.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Answer 4

Question

Chapter 30, Problem 1CS

(1)

Summary Introduction

To determine:

How does the octreotide (Sandostatin) work to control VIPoma-related diarrhea?

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness.

(2)

Summary Introduction

To predict:

J.R. begins the octreotide (Sandostatin) therapy, what parameters the nurse should assess.

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness.

(3)

Summary Introduction

To determine:

What is an explanation for this elevation?

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness. After two days of octreotide (Sandostatin) therapy, the episodes of diarrhea have been reduced. The nurse records that her blood glucose levels are elevated.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Answer 5

Chapter 30, Problem 1CS

(1)

Summary Introduction

To determine:

How does the octreotide (Sandostatin) work to control VIPoma-related diarrhea?

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness.

(2)

Summary Introduction

To predict:

J.R. begins the octreotide (Sandostatin) therapy, what parameters the nurse should assess.

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness.

(3)

Summary Introduction

To determine:

What is an explanation for this elevation?

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness. After two days of octreotide (Sandostatin) therapy, the episodes of diarrhea have been reduced. The nurse records that her blood glucose levels are elevated.

Answer 6

Chapter 30, Problem 1CS

(1)

Summary Introduction

To determine:

How does the octreotide (Sandostatin) work to control VIPoma-related diarrhea?

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness.

Answer 7

Chapter 30, Problem 1CS

(1)

Summary Introduction

To determine:

How does the octreotide (Sandostatin) work to control VIPoma-related diarrhea?

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness.

Answer 8

(2)

Summary Introduction

To predict:

J.R. begins the octreotide (Sandostatin) therapy, what parameters the nurse should assess.

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness.

Answer 9

(2)

Summary Introduction

To predict:

J.R. begins the octreotide (Sandostatin) therapy, what parameters the nurse should assess.

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness.

Answer 10

(3)

Summary Introduction

To determine:

What is an explanation for this elevation?

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness. After two days of octreotide (Sandostatin) therapy, the episodes of diarrhea have been reduced. The nurse records that her blood glucose levels are elevated.

Answer 11

(3)

Summary Introduction

To determine:

What is an explanation for this elevation?

Case summary:

J.R. is a 56-year-old beautician, is diagnosed with a vasoactive intestinal peptide-producing tumor (VIPoma). She was scheduled for her surgery to treat cancer but developed severe diarrhea. She became dehydrated after two days of profuse, watery diarrhea, hence, she has been hospitalized. She has not taken food for several days. Also, she has nausea and facial flushing and lost five pounds in two days. Intravenous fluid replacement with saline has been started. J.R. will be receiving octreotide (Sandostatin). Eight years ago her gallbladder was removed and she has no other history of illness. After two days of octreotide (Sandostatin) therapy, the episodes of diarrhea have been reduced. The nurse records that her blood glucose levels are elevated.

Answer 12

Expert Solution & Answer

Answer 13

Expert Solution & Answer

Answer 14

Want to see the full answer?

Check out a sample textbook solution

See solution

Answer 15

Ch. 30 - Prob. 1O Ch. 30 - Prob. 2O Ch. 30 - Prob. 3O Ch. 30 - Prob. 1CS Ch. 30 - Prob. 1NERQ Ch. 30 - Prob. 2NERQ Ch. 30 - Prob. 3NERQ Ch. 30 - Prob. 4NERQ Ch. 30 - Prob. 5NERQ Ch. 30 - Prob. 6NERQ

Want to see the full answer?

Chapter 30 Solutions